stage i bladder cancer ajcc v8
Showing 1 - 6 of 6
High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8
Not yet recruiting
- High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
- +3 more
- PD-L1/IDO Peptide Vaccine
- Pembrolizumab
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Apr 24, 2023
Stage I Bladder Cancer AJCC v8, Stage II Bladder Cancer AJCC v8, Stage III Bladder Cancer AJCC v8 Trial in Houston
Active, not recruiting
- Stage I Bladder Cancer AJCC v8
- +4 more
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Oct 20, 2022
Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8, Stage I Bladder Cancer AJCC v8 Trial in Buffalo (Behavioral
Recruiting
- Stage 0a Bladder Cancer AJCC v8
- +2 more
- Behavioral Dietary Intervention
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Sep 26, 2022
Bladder Urothelial Carcinoma In Situ, Infiltrating Bladder Mixed Carcinoma, Stage 0a Bladder Cancer AJCC v8 Trial in Guam,
Recruiting
- Bladder Urothelial Carcinoma In Situ
- +4 more
- Gemcitabine Hydrochloride
- Pembrolizumab
-
Birmingham, Alabama
- +379 more
Aug 23, 2022
Remote Telemonitoring of Patient-Generated Physiologic Health
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +171 more
- Patient Monitoring
- Questionnaire Administration
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Bladder Urothelial Carcinoma In Situ, Recurrent Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8 Trial in Seattle
Recruiting
- Bladder Urothelial Carcinoma In Situ
- +5 more
- Acupuncture Therapy
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
May 27, 2022